Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan · Delayed Price · Currency is JOD 1.720
-0.010 (-0.58%)
At close: May 21, 2026
ASE:PHIL Cash Flow Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1.04 | 1.01 | 0.82 | 0.81 | 0.7 | 0.41 |
Depreciation & Amortization | 0.17 | 0.24 | 0.28 | 0.29 | 0.12 | 0.16 |
Other Amortization | 0.37 | 0.29 | 0.3 | 0.3 | 0.25 | 0.1 |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.01 | - | - | - |
Provision & Write-off of Bad Debts | - | - | - | - | - | 0.01 |
Other Operating Activities | 0.33 | 0.42 | 0.36 | 0.37 | 0.27 | 0.57 |
Change in Accounts Receivable | 0 | -0.15 | 0.07 | -0.2 | 0.46 | 1.94 |
Change in Inventory | -0.98 | -0.37 | -0.01 | -0.48 | 0.25 | 0.46 |
Change in Accounts Payable | 0.1 | 0.11 | -0.13 | 0.22 | 0.04 | -0.14 |
Change in Other Net Operating Assets | 0.14 | -0.15 | 0.04 | -0.21 | 0.02 | -0.37 |
Operating Cash Flow | 1.13 | 1.37 | 1.72 | 1.1 | 2.11 | 3.15 |
Operating Cash Flow Growth | -46.02% | -20.31% | 56.55% | -47.82% | -33.02% | 84.84% |
Capital Expenditures | -0.26 | -0.21 | -0.19 | -0.07 | -0.17 | -0.2 |
Sale of Property, Plant & Equipment | 0.08 | 0.06 | 0.03 | - | 0.03 | 0.04 |
Sale (Purchase) of Intangibles | - | - | - | -0.01 | -1.82 | -2.49 |
Sale (Purchase) of Real Estate | -0 | -0 | -0.92 | - | - | - |
Investing Cash Flow | -0.18 | -0.16 | -1.08 | -0.07 | -1.96 | -2.66 |
Short-Term Debt Issued | - | - | - | - | 0.38 | - |
Long-Term Debt Issued | - | - | 1.31 | - | - | - |
Total Debt Issued | 0.08 | - | 1.31 | - | 0.38 | - |
Short-Term Debt Repaid | - | -0.16 | -0.82 | -0.34 | - | -0.19 |
Long-Term Debt Repaid | - | -0.07 | - | - | - | - |
Total Debt Repaid | -0.23 | -0.23 | -0.82 | -0.34 | - | -0.19 |
Net Debt Issued (Repaid) | -0.15 | -0.23 | 0.49 | -0.34 | 0.38 | -0.19 |
Common Dividends Paid | -0.53 | -0.53 | -0.53 | -0.45 | -0.45 | - |
Other Financing Activities | -0.29 | -0.29 | -0.35 | -0.34 | -0.24 | -0.23 |
Financing Cash Flow | -0.97 | -1.04 | -0.38 | -1.12 | -0.31 | -0.43 |
Net Cash Flow | -0.01 | 0.17 | 0.25 | -0.1 | -0.16 | 0.06 |
Free Cash Flow | 0.88 | 1.16 | 1.53 | 1.03 | 1.94 | 2.94 |
Free Cash Flow Growth | -54.83% | -24.16% | 47.69% | -46.74% | -34.02% | 88.22% |
Free Cash Flow Margin | 9.73% | 12.63% | 17.43% | 12.30% | 23.07% | 44.57% |
Free Cash Flow Per Share | 0.12 | 0.15 | 0.20 | 0.14 | 0.26 | 0.39 |
Cash Interest Paid | 0.29 | 0.29 | 0.35 | 0.34 | - | 0.23 |
Cash Income Tax Paid | 0.19 | 0.13 | 0.22 | 0.18 | 0.13 | 0.02 |
Levered Free Cash Flow | 0.35 | 0.67 | 1.01 | 0.52 | -0.28 | -0.16 |
Unlevered Free Cash Flow | 0.54 | 0.85 | 1.24 | 0.73 | -0.13 | -0.02 |
Change in Working Capital | -0.74 | -0.56 | -0.02 | -0.67 | 0.77 | 1.9 |